The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Summarizing historical information on controls in clinical trials
Abstract
Background Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups. Purpose Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized. Methods The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size). Results For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data. Limitations The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed. Conclusions The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well. Clinical Trials 2010; 7: 5—18. http://ctj.sagepub.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Decision Theory and Bayesian Analysis
Berger, J. O. (1985) · Springer Series in Statistics · doi:10.1007/978-1-4757-4286-2 · Cited by 7,722
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Stastical Decision Theory and Bayesian Analysis.
Ghosh, M., & Berger, J. (1988) · Journal of the American Statistical Association · doi:10.2307/2288950 · Cited by 2,905
A Re-Evaluation of Random-Effects Meta-Analysis
Higgins, J. P. T., Thompson, S. G., & Spiegelhalter, D. J. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2008.00552.x · Cited by 2,569
Self-citationRandom-effects model for meta-analysis of clinical trials: An update
DerSimonian, R., & Kacker, R. (2007) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.04.004 · Cited by 2,374
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Self-citationPrior distributions for variance parameters in hierarchical modelsPreprint
Gelman, A. (2004) · RePEc: Research Papers in Economics · Cited by 1,632
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
Meta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Assessing Evidence Inconsistency in Mixed Treatment Comparisons
Lu, G., & Ades, A. E. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000001302 · Cited by 756
Power prior distributions for regression models
Chen, M.-H., & Ibrahim, J. G. (2000) · Statistical Science · doi:10.1214/ss/1009212673 · Cited by 732
Treatment of Ulcerative Colitis with a Humanized Antibody to the α 4 β 7 Integrin
Feagan, B. G., Greenberg, G. R., Wild, G., Fedorak, R. N., Paré, P., McDonald, J. W. D., Dubé, R., Cohen, A., Steinhart, A. H., Landau, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042982 · Cited by 692
Consensus Values and Weighting Factors
Paule, R. C., & Mandel, J. (1982) · Journal of Research of the National Bureau of Standards · doi:10.6028/jres.087.022 · Cited by 572
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS
HIGGINS, J. P. T., & WHITEHEAD, A. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961230)15:24<2733::aid-sim562>3.0.co;2-0 · Cited by 557
A LIKELIHOOD APPROACH TO META-ANALYSIS WITH RANDOM EFFECTS
HARDY, R. J., & THOMPSON, S. G. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960330)15:6<619::aid-sim188>3.0.co;2-a · Cited by 522
The combination of randomized and historical controls in clinical trials
Pocock, S. J. (1976) · Journal of Chronic Diseases · doi:10.1016/0021-9681(76)90044-8 · Cited by 514
Bias Modelling in Evidence Synthesis
Turner, R. M., Spiegelhalter, D. J., Smith, G. C. S., & Thompson, S. G. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2008.00547.x · Cited by 321
Self-citationBayesian Approaches to Clinical Trials and Health-Care Evaluation
Best, M. A. (2005) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2004.00347_17.x · Cited by 303
Warn, D. E., Thompson, S. G., & Spiegelhalter, D. J. (2002) · Statistics in Medicine · doi:10.1002/sim.1189 · Cited by 277
Self-citationCampbell, M. K., Fayers, P. M., & Grimshaw, J. M. (2005) · Clinical Trials · doi:10.1191/1740774505cn071oa · Cited by 275
META-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
DERSIMONIAN, R. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960630)15:12<1237::aid-sim301>3.0.co;2-n · Cited by 257
Determining the Effective Sample Size of a Parametric Prior
Morita, S., Thall, P. F., & Müller, P. (2008) · Biometrics · doi:10.1111/j.1541-0420.2007.00888.x · Cited by 257
Meta-Analysis in Medicine and Health Policy
(2000) · CRC Press eBooks · doi:10.1201/9780203909935 · Cited by 211
Neuenschwander, B., Branson, M., & Spiegelhalter, D. J. (2009) · Statistics in Medicine · doi:10.1002/sim.3722 · Cited by 195
Self-citationA prior for the variance in hierarchical models
Daniels, M. J. (1999) · Canadian Journal of Statistics · doi:10.2307/3316112 · Cited by 176
Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
Racine, A., Grieve, A. P., Fluhler, H., & Smith, A. F. M. (1986) · Applied Statistics · doi:10.2307/2347264 · Cited by 170
Investigating Therapies of Potentially Great Benefit: ECMO
Ware, J. H. (1989) · Statistical Science · doi:10.1214/ss/1177012384 · Cited by 170
The Use of Historical Control Information in Testing for a Trend in Proportions
Tarone, R. E. (1982) · Biometrics · doi:10.2307/2530304 · Cited by 161
MeWAnalysis by the Confidence Profile Method: The Statistical Synthesis of Evidence
Lenth, R. V., Eddy, D. M., Hasselblad, V., & Shachter, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10485067 · Cited by 148
Assche, G. V., Sandborn, W. J., Feagan, B. G., Salzberg, B. A., Silvers, D., Monroe, P. S., Pandak, W. M., Anderson, F., Valentine, J. F., Wild, G., et al. (2006) · Gut · doi:10.1136/gut.2005.089854 · Cited by 143
Statistical Methodology in the Pharmaceutical Sciences
Berry, D. A. (2014) · CRC Press eBooks · doi:10.1201/b16950 · Cited by 138
Bayesian methods for cluster randomized trials with continuous responses
Spiegelhalter, D. J. (2001) · Statistics in Medicine · doi:10.1002/1097-0258(20010215)20:3<435::aid-sim804>3.0.co;2-e · Cited by 137
Self-citationCombining Historical and Randomized Controls for Assessing Trends in Proportions
Dempster, A. P., Selwyn, M. R., & Weeks, B. J. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477953 · Cited by 126
The relationship between the power prior and hierarchical models
Chen, M., & Ibrahim, J. G. (2006) · Bayesian Analysis · doi:10.1214/06-ba118 · Cited by 113
Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs
Dominici, F., Parmigiani, G., Wolpert, R. L., & Hasselblad, V. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10473815 · Cited by 90
Incorporating historical control data in planning phase II clinical trials
Thall, P. F., & Simon, R. M. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090304 · Cited by 82
Meta-Analysis by the Confidence Profile Method: The Statistical Synthesis of Evidence
Lenth, R. V., Eddy, D. M., Hasselblad, V., & Shachter, R. D. (1993) · Technometrics · doi:10.2307/1269690 · Cited by 80
Robust bayesian methods for monitoring clinical trials
Greenhouse, J. B., & Waserman, L. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141210 · Cited by 75
[Investigating Therapies of Potentially Great Benefit: ECMO]: Comment: A Bayesian Perspective
Kass, R. E., & Greenhouse, J. B. (1989) · Statistical Science · doi:10.1214/ss/1177012386 · Cited by 74
Projection from previous studies: A Bayesian and frequentist compromise
Brown, B. W., Herson, J., Atkinson, E. N., & Rozell, M. E. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90023-7 · Cited by 59
Goodman, S. N., & Sladky, J. T. (2005) · Clinical Trials · doi:10.1191/1740774505cn102oa · Cited by 50
Hierarchical Models for Combining Information and for Meta-Analyses
Morris, C. N., & Normand, S. T. (1992) · Oxford University Press eBooks · doi:10.1093/oso/9780198522669.003.0018 · Cited by 45
A Bayesian re-assessment of two Phase II trials of gemcitabine in metastatic nasopharyngeal cancer
Tan, S.-B., Machin, D., Tai, B.-C., Foo, K., & Tan, E. H. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600199 · Cited by 27
On the Use of Historical Control Data in Pre-Clinical Safety Studies
Maringwa, J. T., Faes, C., Aerts, M., Geys, H., Teuns, G., Poel, B. V. D., & Bijnens, L. (2007) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400701216355 · Cited by 11
Meta-analysis: formulating, evaluating, combining, and reporting
Normand, S.-L. T. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p
Cited by
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Baeten, D., Baraliakos, X., Braun, J., Sieper, J., Emery, P., van der Heijde, D., McInnes, I., van Laar, J. M., Landewé, R., Wordsworth, P., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61134-4 · Cited by 595
Use of historical control data for assessing treatment effects in clinical trials
Viele, K., Berry, S., Neuenschwander, B., Amzal, B., Chen, F., Enas, N., Hobbs, B., Ibrahim, J. G., Kinnersley, N., Lindborg, S., et al. (2014) · Pharmaceutical Statistics · doi:10.1002/pst.1589 · Cited by 512
Self-citationRobust meta‐analytic‐predictive priors in clinical trials with historical control information
Schmidli, H., Gsteiger, S., Roychoudhury, S., O'Hagan, A., Spiegelhalter, D., & Neuenschwander, B. (2014) · Biometrics · doi:10.1111/biom.12242 · Cited by 482
Self-citationFracture risk and zoledronic acid therapy in men with osteoporosis
Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204061 · Cited by 359
Metadata
- Authors
- Neuenschwander, B., Capkun-Niggli, G., Branson, M., & Spiegelhalter, D. J.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 7
- Issue
- 1
- Pages
- 5-18
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2010622913
- Cited by
- 396
- References
- 49
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.